WO2008061673A3 - Drug discovery for cancer - Google Patents
Drug discovery for cancer Download PDFInfo
- Publication number
- WO2008061673A3 WO2008061673A3 PCT/EP2007/009910 EP2007009910W WO2008061673A3 WO 2008061673 A3 WO2008061673 A3 WO 2008061673A3 EP 2007009910 W EP2007009910 W EP 2007009910W WO 2008061673 A3 WO2008061673 A3 WO 2008061673A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- gamma
- cancer
- secretase
- collection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to a method for identifying compounds which alter the activity of gamma- secretase, comprising providing a collection of compounds; contacting the compounds of the collection with a cell line or organism expressing gamma-secretase; measuring the gamma-secretase activity in the cell line or organism before and after the contact with the compound; and identifying the compounds in the collection that modulate the gamma-secretase activity of the cell line or organism as leads for the development of compounds for use in the treatment of cancer. The invention further relates to the compound thus identified and the use thereof in therapy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2006011266 | 2006-11-24 | ||
EPPCT/EP2006/011266 | 2006-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008061673A2 WO2008061673A2 (en) | 2008-05-29 |
WO2008061673A3 true WO2008061673A3 (en) | 2008-10-02 |
Family
ID=39272707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/009910 WO2008061673A2 (en) | 2006-11-24 | 2007-11-08 | Drug discovery for cancer |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008061673A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073630A2 (en) * | 2003-02-18 | 2004-09-02 | Roskamp Research Llc | Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
WO2004104037A1 (en) * | 2003-05-26 | 2004-12-02 | Sanofi-Aventis Deutschland Gmbh | Method for screening inhibitors of the gamma-secretase |
EP1702626A1 (en) * | 2003-12-30 | 2006-09-20 | Kowa Company Ltd. | Inhibitor for the formation of gammad-secretase complex |
WO2007028655A2 (en) * | 2005-09-09 | 2007-03-15 | H. Lundbeck A/S | Drug discovery for neurodevelopmental disorders and their complications |
-
2007
- 2007-11-08 WO PCT/EP2007/009910 patent/WO2008061673A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073630A2 (en) * | 2003-02-18 | 2004-09-02 | Roskamp Research Llc | Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
WO2004104037A1 (en) * | 2003-05-26 | 2004-12-02 | Sanofi-Aventis Deutschland Gmbh | Method for screening inhibitors of the gamma-secretase |
EP1702626A1 (en) * | 2003-12-30 | 2006-09-20 | Kowa Company Ltd. | Inhibitor for the formation of gammad-secretase complex |
WO2007028655A2 (en) * | 2005-09-09 | 2007-03-15 | H. Lundbeck A/S | Drug discovery for neurodevelopmental disorders and their complications |
Non-Patent Citations (1)
Title |
---|
SHIROTANI KEIRO ET AL: "Identification of distinct gamma-secretase complexes with different APH-1 variants", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 279, no. 40, 1 October 2004 (2004-10-01), pages 41340 - 41345, XP002418773, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008061673A2 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG170826A1 (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor | |
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
WO2008021183A3 (en) | For the identification, assessment, and treatment of patients with cancer therapy | |
EA201100452A1 (en) | TREATMENT OF INFLAMMATORY CONDITIONS | |
WO2010008739A3 (en) | Aryl gpr119 agonists and uses thereof | |
WO2009085234A3 (en) | Use of micro-rna as a biomarker of immunomodulatory drug activity | |
WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
WO2012062925A3 (en) | Compounds and methods for treating pain | |
WO2009079587A3 (en) | Biomarkers for sensitivity to anti-igf1r therapy | |
WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
WO2007123722A3 (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
WO2013009655A3 (en) | Uses of labeled hsp90 inhibitors | |
WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
WO2012078623A3 (en) | Biomarkers for monitoring treatment of neuropsychiatric diseases | |
MY158428A (en) | Topical composition for the treatment of actinic keratosis | |
WO2008013966A3 (en) | Use of 8-quinolinol and its analogs to target cancer stem cells | |
WO2008127388A3 (en) | Use of quantum system identification and quantum control techniques for medical diagnostic and therapeutic purposes | |
WO2009075797A3 (en) | Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphoma | |
MX2009008727A (en) | Patch for cutaneous application. | |
WO2008118390A3 (en) | Biomarkers for diagnostic and therapeutic methods | |
ZA201007061B (en) | Pyridopyrazinones derivatives insulin secretion stimulators,methods for obtaining them and use thereof for the treatment of diabetes | |
EA201101300A1 (en) | METHOD OR SYSTEM BASED ON BIOMARKERS INTENDED FOR MONITORING TREATMENT | |
WO2008155390A3 (en) | Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. | |
WO2009022988A3 (en) | Vhz for diagnosis and treatment of cancer | |
GB2473575B (en) | Diagnosis of autism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07846619 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07846619 Country of ref document: EP Kind code of ref document: A2 |